These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20832595)

  • 61. Kidney Transplantation in Patients With Active Multiple Myeloma: Case Reports.
    Lum EL; Kogut N; Pham T; Danovitch GM; Bunnapradist S
    Transplant Direct; 2017 Aug; 3(8):e200. PubMed ID: 28795151
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Multiple myeloma post renal transplant: one case report and literature review].
    Wu W; Xie X; Gu W; Liu D; Zhu Y; Li Q
    Zhonghua Xue Ye Xue Za Zhi; 2015 Mar; 36(3):250-2. PubMed ID: 25854475
    [No Abstract]   [Full Text] [Related]  

  • 63. [The kidney transplant recipient].
    Coppo R
    G Ital Nefrol; 2011; 28(3):243-4. PubMed ID: 21626483
    [No Abstract]   [Full Text] [Related]  

  • 64. Bortezomib-Induced Superficial Vasculitis in a Kidney Transplant Recipient: A Rare Case.
    Balwani M; Pasari A; Gurjar P; Sejpal K; Bawankule C; Tolani P; Dubey S; Kashiv P; Bhawane A; Malde S; Gupta S
    Cureus; 2024 Apr; 16(4):e58743. PubMed ID: 38779283
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Donor or recipient origin of post transplant lymphoproliferative disease after lung transplantation.
    Verschuuren EA; Popa ER; Van Der Bij W; Harmsen MC; The TH; Hepkema B
    J Heart Lung Transplant; 2001 Feb; 20(2):199. PubMed ID: 11250350
    [No Abstract]   [Full Text] [Related]  

  • 66. Short Term Renal Outcome of Bortezomib Based Therapy in Patients with Multiple Myeloma Requiring Dialysis.
    Pandey AK; Agarwal D; Rathore V; Sharma GS; Nowal SS; Beniwal P; Jhorawat R; Malhotra V; Sharma S
    Indian J Nephrol; 2020; 30(3):213-214. PubMed ID: 33013077
    [No Abstract]   [Full Text] [Related]  

  • 67. [Recent advancement of renal transplantation at home and abroad].
    Shi BY; Yuan Q
    Zhonghua Yi Xue Za Zhi; 2017 Jan; 97(2):81-84. PubMed ID: 28088949
    [No Abstract]   [Full Text] [Related]  

  • 68. A 54-Year-Old Woman with Donor Cell Origin of Multiple Myeloma after Allogeneic Hematopoietic Stem Cell Transplantation for the Treatment of CML.
    Maestas E; Jain S; Stiff P
    Case Rep Hematol; 2016; 2016():6751914. PubMed ID: 26989529
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stable renal engraftment in a patient following successful tandem autologous/reduced-intensity conditioning allogeneic transplantation for treatment of multiple myeloma with del(17p) that developed as a post-transplantation lymphoproliferative disease following renal transplantation.
    Aoki T; Kasai M; Harada Y; Matsubara E; Morishita T; Suzuki T; Tsujita M; Goto N; Katayama A; Watarai Y; Uchida K; Ito M; Saji H; Tsuzuki T; Uchida T; Ogura M
    Int J Hematol; 2013 Jul; 98(1):129-34. PubMed ID: 23666631
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder.
    Hatton O; Martinez OM; Esquivel CO
    Pediatr Transplant; 2012 May; 16(3):220-9. PubMed ID: 22353174
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Post-transplant multiple myeloma in a pediatric renal transplant patient.
    Tcheng WY; Said J; Hall T; Al-Akash S; Malogolowkin M; Feig SA
    Pediatr Blood Cancer; 2006 Aug; 47(2):218-23. PubMed ID: 16086426
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Incidence and consequences of post-transplantation lymphoproliferative disorders.
    Boubenider S; Hiesse C; Goupy C; Kriaa F; Marchand S; Charpentier B
    J Nephrol; 1997; 10(3):136-45. PubMed ID: 9238621
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cost of paid transplantation abroad: possible donor-origin early multiple myeloma in a renal transplant recipient treated using bortezomib.
    Solak Y; Atalay H; Anil M; Aydogdu I; Tonbul HZ
    Transplant Proc; 2010 Sep; 42(7):2813-5. PubMed ID: 20832595
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hodgkin disease-like posttransplantation lymphoproliferative disorder of donor origin in a renal allograft recipient.
    Schlieper G; Kurschat C; Donner A; Huckenbeck W; Rüdiger T; Sandmann W; Grabensee B; Ivens K; Heering P
    Am J Kidney Dis; 2006 Mar; 47(3):e37-41. PubMed ID: 16490613
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Post-transplant lymphoproliferative disorders after live donor renal transplantation.
    Jain M; Badwal S; Pandey R; Srivastava A; Sharma RK; Gupta RK
    Clin Transplant; 2005 Oct; 19(5):668-73. PubMed ID: 16146560
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Microsatellite analysis in post-transplantation lymphoproliferative disorder to determine donor/recipient origin.
    Ng IO; Shek TW; Thung SN; Ye MM; Lo CM; Fan ST; Lee JM; Chan KW; Cheung AN
    Mod Pathol; 2000 Nov; 13(11):1180-5. PubMed ID: 11106074
    [TBL] [Abstract][Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.